+
Site Tour
SETTING THE PACE WITH
AVEIR™ LEADLESS
PACEMAKERS


The only leadless solutions that can provide therapy
for all common pacemaker indications1,2,3

THE AVEIR™ DR LEADLESS PACEMAKER (LP) SYSTEM

A FIRST-OF-ITS KIND, DUAL-CHAMBER LEADLESS PACING SYSTEM FEATURING:

BEAT-TO-BEAT SYNCHRONY BETWEEN BOTH CHAMBERS4
Sensing and pacing in both the right atrial and right ventricular chambers

LONG TERM RETRIEVAL4,5
No hardware is left behind to provide options for future patient needs or therapies

ELECTRICAL MAPPING PRIOR TO FIXATION4
Reduces the number of repositioning attempts to find your optimal implant site

UPGRADEABLE SYSTEM WITH AAI(R), VVI(R), AAI(R)+VVI†, AND DDD(R) OPTIONS4
Match your patients’ pacing needs and upgrade over time as those needs change

†AAI(R)+VVI mode should not be used in patients without intact AV node conduction, or with chronic atrial fibrillation or atrial flutter.

AAI(R), atrial pacing rate response; DDD(R), dual-chamber pacing rate response; VVI, single chamber ventricular pacing; VVI(R), single chamber ventricular pacing rate response.

Long-term retrieval

The helical fixation mechanism is designed for end-of-service retrieval and future therapy options4,6,7

Electrical mapping prior to fixation

The electrical mapping capability of each AVEIR™ LP is designed to help reduce the number of repositioning attempts.

  • Every AVEIR™ LP can measure P/R-waves, impedance and current of injury via commanded electrogram (EGM), and an initial capture threshold before fixation by simply touching the tip electrode to the endocardial tissue.4,8
  • AVEIR™ LP is fixated with a rotational motion into the endocardium.4
Extended battery life

COMPARABLE LONGEVITY TO TRANSVENOUS PACEMAKERS WITH OPTIMIZED PROGRAMMING9
 

Single-center study [AR (n=17), VR (n=100), DR (n=100)].
† AAI(R)+VVI mode should not be used in patients without intact AV node conduction, or with chronic atrial fibrillation or atrial flutter.
AAI, atrial pacing; ALP, atrial leadless pacemaker; AR, atrial device; DDD, dual-chamber pacing; DDD(R), dual-chamber pacing rate response;
DR, dual-chamber device; VLP, ventricular leadless pacemaker; VR, ventricular device; VVI, single chamber ventricular pacing.

“

We demonstrated battery longevities that are comparable and can exceed those
 of transvenous pacemakers despite the reduced LP battery capacities9

James E. Ip, Professor of Medicine, Weill Cornell Medical College

Connext
TV

CONNECT TO THE LATEST
IN STRUCTURAL HEART
THERAPY

Find out more

TV

References
  1. AVEIR™ Leadless Pacemakers and Delivery Catheter IFU. ARTEN600361108.
  2. Micra‡ VR2 MC2VR01 IFU.
  3. Micra‡ AV2 MC2AVR1 IFU.
  4. AVEIR™ Leadless Pacemakers and Delivery Catheter IFU. ARTEN600307044. ARTEN600350965.
  5. Neuzil P, Exner DV, Knops RE, et al. Worldwide Chronic Retrieval Experience of Helix-Fixation Leadless Cardiac Pacemakers. J Am Coll Cardiol. 2025;85(11):1111-1120. doi: 10.1016/j.jacc.2024.10.094. 
  6. AVEIR™ Retrieval Catheter IFU. ARTMT600167676.
  7. Reddy, VY, et al. Worldwide Experience with Leadless Pacemaker Retrievals: A Worldwide Nanostim Experience out of 9y. Presented at: Asia Pacific Heart Rhythm Society; Nov 18-20, 2022; Singapore. 
  8. Knops RE, Reddy VY, Ip JE, et al. A Dual-Chamber Leadless Pacemaker. N Engl J Med. 2023;388(25):2360-2370. doi: 10.1056/NEJMoa2300080.
  9. Ip JE, Cheung JW, Liu CF, et al. Maximizing battery longevity of leadless pacemaker systems by optimizing individualized programming. Heart Rhythm. 2026;23(2):e293-e294. doi: 10.1016/j.hrthm.2025.10.021.

™ indicates a trademark of the Abbott group of companies.
‡ Indicates a third-party trademark, which is property of its respective owner.

© Abbott 2026. All rights reserved. MAT-2676032 v1.0

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline